Scientists at @Oslounivsykehus including Dr. Sean Harrison exploited iPSC-derived liver organoids to provide a testing platform for parenteral 👶 nutrition-associated liver disease, including steatosis, cholestasis, and gallbladder sludge.
https://t.co/M5rGqqLaUy
New collaboration with colleagues from universities in Oslo (Norway), Yale (USA), Hannover (Germany), Durham (UK), and Charles (Czech Republic) on "Scalable production of tissue-like vascularized liver organoids from human PSCs" published in Exp Mol Med https://t.co/dcuUj7RSMb
Technique for producing #bioprinted#vascularized mini-livers, called #organoids, that is actually scalable. The mini-organs closely resemble real livers in structure and have been successfully transplanted into mice. A leap forward for #tissueengineering
https://t.co/53iB16tHn8
Here is latest publication on Scalable Liver Organoids with a liver like milieu of hepatic cells and function, from @sullivanjsullivan lab,
https://t.co/iFhzpJtb4C
Latest review from the Sullivan group and our collaborators in Prague! It provides an overview of the liver organoid landscape.
Liver Organoids: Recent Developments, Limitations and Potential https://t.co/9GU1bpZBPm
Our manuscript on the molecular characterization of two homozygous factor VII variants associated with intracranial bleeding is now available on-line https://t.co/CgFj8kFHIK
New paper by @StevenRayOslo and co-workers: Mass spectrometry-measurements of organoid drug metabolism, following 96-well format electromembrane extraction. #ACSAuthorChoice https://t.co/gegGaghv1N